Clincosm LogoSign in Get a demo

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Sponsor
Heidelberg University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02678832
Collaborator
German Cancer Research Center (Other), University of Heidelberg Medical Center (Other), National Center for Tumor Diseases, Heidelberg (Other), German Cancer Aid (Other)
2,150
Enrollment
27
Duration (Months)

Study Details

Study Description

Brief Summary

The study, investigates the current physical activity promotion practices among physicians and nurses, as well as social norms toward physical activity during treatment among cancer patients and among physicians and nurses who treat or counsel cancer patients.

For this purpose, four large surveys with health care professionals (specialized practitioners, N=300; general practitioners, N=300; oncology nurses, N=300) and cancer patients (N=1200, 400 patients each with breast, prostate or colorectal cancer) with a cross-sectional research design are conducted.

Additionally, a follow-up-study with a sub-sample of cancer patients (N=180) will be conducted.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2150 participants
    Time Perspective:
    Cross-Sectional
    Official Title:
    Social Cognitions and Norms Towards Physical Exercise Among Cancer Patients and Health Care Professionals
    Study Start Date :
    Dec 1, 2015
    Anticipated Primary Completion Date :
    Aug 1, 2017
    Anticipated Study Completion Date :
    Mar 1, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Cancer patients
    Physicians
    Oncology nurses

    Outcome Measures

    Primary Outcome Measures

    1. Social norms and cognitions toward self-management strategies of cancer patients as assessed by the variables of the theory of planned behavior (TPB) [one-time self-report of current cognitions]

      Questionnaire items were developed in a pilot study according to the guidelines for a TPB questionnaire described by Ajzen (2006)

    Secondary Outcome Measures

    1. Physical activity as assessed with SQUASH [one-time retrospective self-report about the past month]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • HCP are eligible if they meet the following inclusion criteria: Working as an oncological nurse, general practitioner or physician specialized in oncology, radiology, surgery, gynecology, urology, gastroenterology or rehabilitation Signed informed consent

    • Patients are eligible if they meet the following inclusion criteria: Patients with a diagnosis of primary tumor or recurrence no longer than 2 years ago who are undergoing chemo- or radiotherapy currently or in the last 2 years Patients undergoing chemo- or radiotherapy currently or no longer than 2 years ago At least 18 years of age Sufficient German language skills Signed informed consent

    Exclusion Criteria:

    • HCP will be excluded from the trial if they meet the following exclusion criteria: No regular contact with cancer patients

    • Patients will be excluded from the trial if they meet the following exclusion criteria: Presence of comorbidities that preclude involvement in exercise programs (e.g. severe pain, advanced heart failure [≥ NYHA III]) Mentally retarded Reduced standing ability and no ability to walk

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Heidelberg University
    • German Cancer Research Center
    • University of Heidelberg Medical Center
    • National Center for Tumor Diseases, Heidelberg
    • German Cancer Aid

    Investigators

    • Principal Investigator: Monika Sieverding, Prof. Dr., Heidelberg University
    • Principal Investigator: Karen Steindorf, Prof. Dr., German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg
    • Principal Investigator: Joachim Wiskemann, Dr., University of Heidelberg Medical Center & National Center for Tumor Diseases (NCT), Heidelberg

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Heidelberg University
    ClinicalTrials.gov Identifier:
    NCT02678832
    Other Study ID Numbers:
    • 110512/111223
    First Posted:
    Feb 10, 2016
    Last Update Posted:
    Feb 17, 2016
    Last Verified:
    Feb 1, 2016
    Additional relevant MeSH terms:
    Colorectal Neoplasms

    Study Results

    No Results Posted as of Feb 17, 2016